Literature DB >> 27050267

Crystal structure of a tankyrase 1-telomere repeat factor 1 complex.

Bo Li1, Ruihong Qiao1, Zhizhi Wang2, Weihong Zhou1, Xin Li1, Wenqing Xu2, Zihe Rao1.   

Abstract

Telomere repeat factor 1 (TRF1) is a subunit of shelterin (also known as the telosome) and plays a critical role in inhibiting telomere elongation by telomerase. Tankyrase 1 (TNKS1) is a poly(ADP-ribose) polymerase that regulates the activity of TRF1 through poly(ADP-ribosyl)ation (PARylation). PARylation of TRF1 by TNKS1 leads to the release of TRF1 from telomeres and allows telomerase to access telomeres. The interaction between TRF1 and TNKS1 is thus important for telomere stability and the mitotic cell cycle. Here, the crystal structure of a complex between the N-terminal acidic domain of TRF1 (residues 1-55) and a fragment of TNKS1 covering the second and third ankyrin-repeat clusters (ARC2-3) is presented at 2.2 Å resolution. The TNKS1-TRF1 complex crystals were optimized using an `oriented rescreening' strategy, in which the initial crystallization condition was used as a guide for a second round of large-scale sparse-matrix screening. This crystallographic and biochemical analysis provides a better understanding of the TRF1-TNKS1 interaction and the three-dimensional structure of the ankyrin-repeat domain of TNKS.

Entities:  

Keywords:  PARylation; TNKS; TRF1; complex structure; tankyrase; telomere; telomere repeat factor 1

Mesh:

Substances:

Year:  2016        PMID: 27050267      PMCID: PMC4822990          DOI: 10.1107/S2053230X16004131

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


  24 in total

Review 1.  Post-translational modifications of TRF1 and TRF2 and their roles in telomere maintenance.

Authors:  John R Walker; Xu-Dong Zhu
Journal:  Mech Ageing Dev       Date:  2012-05-23       Impact factor: 5.432

Review 2.  Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins.

Authors:  Paula Martínez; María A Blasco
Journal:  Nat Rev Cancer       Date:  2011-03       Impact factor: 60.716

3.  Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.

Authors:  Cristina Garcia-Aranda; Carmen de Juan; Antonio Diaz-Lopez; Andres Sanchez-Pernaute; Antonio-Jose Torres; Eduardo Diaz-Rubio; Jose-Luis Balibrea; Manuel Benito; Pilar Iniesta
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

4.  The telomeric poly(ADP-ribose) polymerase, tankyrase 1, contains multiple binding sites for telomeric repeat binding factor 1 (TRF1) and a novel acceptor, 182-kDa tankyrase-binding protein (TAB182).

Authors:  Hiroyuki Seimiya; Susan Smith
Journal:  J Biol Chem       Date:  2002-02-19       Impact factor: 5.157

Review 5.  Telomere-associated proteins: cross-talk between telomere maintenance and telomere-lengthening mechanisms.

Authors:  Gitte De Boeck; Ramses G Forsyth; Marleen Praet; Pancras C W Hogendoorn
Journal:  J Pathol       Date:  2009-02       Impact factor: 7.996

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  Expression of mRNAs for telomeric repeat binding factor (TRF)-1 and TRF2 in atypical adenomatous hyperplasia and adenocarcinoma of the lung.

Authors:  Kuniaki Nakanishi; Toshiaki Kawai; Fumiyuki Kumaki; Sadayuki Hiroi; Makio Mukai; Eiji Ikeda; Catherine Elaine Koering; Eric Gilson
Journal:  Clin Cancer Res       Date:  2003-03       Impact factor: 12.531

Review 8.  The role of shelterin in maintaining telomere integrity.

Authors:  Maria Pia Longhese; Savani Anbalagan; Marina Martina; Diego Bonetti
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01

Review 9.  Tankyrases: structure, function and therapeutic implications in cancer.

Authors:  Teemu Haikarainen; Stefan Krauss; Lari Lehtio
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  7 in total

1.  Molecular Architecture of Full-length TRF1 Favors Its Interaction with DNA.

Authors:  Jasminka Boskovic; Jaime Martinez-Gago; Marinela Mendez-Pertuz; Alberto Buscato; Jorge Luis Martinez-Torrecuadrada; Maria A Blasco
Journal:  J Biol Chem       Date:  2016-08-25       Impact factor: 5.157

Review 2.  Poly(ADP-ribose)-dependent ubiquitination and its clinical implications.

Authors:  Christina A Vivelo; Vinay Ayyappan; Anthony K L Leung
Journal:  Biochem Pharmacol       Date:  2019-05-08       Impact factor: 5.858

3.  Tankyrase1-mediated poly(ADP-ribosyl)ation of TRF1 maintains cell survival after telomeric DNA damage.

Authors:  Lu Yang; Luxi Sun; Yaqun Teng; Hao Chen; Ying Gao; Arthur S Levine; Satoshi Nakajima; Li Lan
Journal:  Nucleic Acids Res       Date:  2017-04-20       Impact factor: 16.971

4.  Structural and functional analysis of parameters governing tankyrase-1 interaction with telomeric repeat-binding factor 1 and GDP-mannose 4,6-dehydratase.

Authors:  Travis Eisemann; Marie-France Langelier; John M Pascal
Journal:  J Biol Chem       Date:  2019-08-02       Impact factor: 5.157

5.  Structural basis for tankyrase-RNF146 interaction reveals noncanonical tankyrase-binding motifs.

Authors:  Paul A DaRosa; Rachel E Klevit; Wenqing Xu
Journal:  Protein Sci       Date:  2018-04-25       Impact factor: 6.725

6.  Identifying and Validating Tankyrase Binders and Substrates: A Candidate Approach.

Authors:  Katie Pollock; Michael Ranes; Ian Collins; Sebastian Guettler
Journal:  Methods Mol Biol       Date:  2017

7.  Leukocyte telomere length, allelic variations in related genes and risk of coronary heart disease in people with long-standing type 1 diabetes.

Authors:  Manuel Sanchez; Caroline Kannengiesser; Sophie Hoang; Louis Potier; Frédéric Fumeron; Nicolas Venteclef; André Scheen; Jean-François Gautier; Samy Hadjadj; Michel Marre; Ronan Roussel; Kamel Mohammedi; Gilberto Velho
Journal:  Cardiovasc Diabetol       Date:  2022-10-11       Impact factor: 8.949

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.